Great Debate 2025 spotlights BIOLOX® delta ceramic and resurfacing
The biannual event promises two days of dynamic discussion around current issues and news in THA and TKA. This year’s topics included patient selection and management, technologies, outcomes, case presentations, robotics, and the resurfacing approach that originated in the UK.
The program was punctuated by standout presentations. Dr. Steven MacDonald of Canada advocated for THA procedures using modern composite ceramic such as BIOLOX®delta, citing excellent registry outcomes, cost-effectiveness, and no issues with fracture, among other reasons. He pointed out the superior durability of BIOLOX®delta ceramic when paired with a highly-cross-linked-polyethylene (HXLPE) liner.
The UK’s Prof. Cobb (Imperial College London) of Embody Orthopaedics, who designed and developed the H1® BIOLOX®delta ceramic hip resurfacing in collaboration with CeramTec and Medicoat, gave an overview of the device’s current clinical study and highlighted early results in which resurfacing outperforms conventional THA in its preservation of a patient’s gait, speed, and range of motion.
Meanwhile, Prof. Bill Walter of Australia, a leading design surgeon using MatOrtho’s BIOLOX®delta ceramic-on-ceramic (CoC) ReCerf®, expounded on the possibilities offered by ceramic in resurfacing. Among other improvements from metal, Prof. Walter noted, ceramic materials can make implants viable for women under 55 (as well as men under 65), dramatically reduce the risk of revision (10 cases in 1,000 procedures performed), and foster conditions compatible with femoral heads of any size, no matter how small.